Logo image of CELL.CA

GRID BATTERY METALS INC (CELL.CA) Stock Fundamental Analysis

TSX-V:CELL - TSX Venture Exchange - CA3980841033 - Common Stock - Currency: CAD

0.04  0 (0%)

Fundamental Rating

2

Taking everything into account, CELL scores 2 out of 10 in our fundamental rating. CELL was compared to 806 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for CELL as it has an excellent financial health rating, but there are worries on the profitability. CELL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CELL had negative earnings in the past year.
CELL had a negative operating cash flow in the past year.
In the past 5 years CELL reported 4 times negative net income.
CELL had a negative operating cash flow in each of the past 5 years.
CELL.CA Yearly Net Income VS EBIT VS OCF VS FCFCELL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M -3M -4M

1.2 Ratios

With a Return On Assets value of -73.80%, CELL is not doing good in the industry: 69.98% of the companies in the same industry are doing better.
The Return On Equity of CELL (-73.89%) is worse than 60.92% of its industry peers.
Industry RankSector Rank
ROA -73.8%
ROE -73.89%
ROIC N/A
ROA(3y)-60.06%
ROA(5y)-75.04%
ROE(3y)-60.83%
ROE(5y)-85.8%
ROIC(3y)N/A
ROIC(5y)N/A
CELL.CA Yearly ROA, ROE, ROICCELL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CELL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CELL.CA Yearly Profit, Operating, Gross MarginsCELL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for CELL has been increased compared to 1 year ago.
Compared to 5 years ago, CELL has more shares outstanding
The debt/assets ratio for CELL has been reduced compared to a year ago.
CELL.CA Yearly Shares OutstandingCELL.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CELL.CA Yearly Total Debt VS Total AssetsCELL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 677.75 indicates that CELL is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 677.75, CELL belongs to the best of the industry, outperforming 99.75% of the companies in the same industry.
There is no outstanding debt for CELL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 677.75
ROIC/WACCN/A
WACCN/A
CELL.CA Yearly LT Debt VS Equity VS FCFCELL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 276.79 indicates that CELL has no problem at all paying its short term obligations.
CELL's Current ratio of 276.79 is amongst the best of the industry. CELL outperforms 99.63% of its industry peers.
CELL has a Quick Ratio of 276.79. This indicates that CELL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 276.79, CELL belongs to the top of the industry, outperforming 99.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 276.79
Quick Ratio 276.79
CELL.CA Yearly Current Assets VS Current LiabilitesCELL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

CELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -941.67%.
EPS 1Y (TTM)-941.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CELL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CELL.CA Price Earnings VS Forward Price EarningsCELL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CELL.CA Per share dataCELL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CELL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GRID BATTERY METALS INC

TSX-V:CELL (7/30/2025, 7:00:00 PM)

0.04

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.63%
Ins Owner ChangeN/A
Market Cap7.74M
Analysts80
Price Target0.19 (375%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.5
P/tB 1.5
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -73.8%
ROE -73.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-60.06%
ROA(5y)-75.04%
ROE(3y)-60.83%
ROE(5y)-85.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5506.6%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 276.79
Quick Ratio 276.79
Altman-Z 677.75
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3609.95%
Cap/Depr(5y)2655.97%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-941.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1996.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1796.28%
OCF growth 3YN/A
OCF growth 5YN/A